Download Files:

TAK-901

SKU T2709-5 mg Category Small Compound Brand: TargetMol

Price range: 106 CAD through 626 CAD

For Research Use Only (RUO). This product is sold strictly for laboratory research use. Not for human or veterinary consumption, therapeutic, or diagnostic use.For sale to research organizations and laboratories only; not for patients or for personal use.

Size

25 mg 5 mg 50 mg

Clear

Products Details

Product Description

– TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.

For Research Use Only (RUO). This product is sold strictly for laboratory research use only. Not for human or veterinary consumption, therapeutic, or diagnostic use. Any pharmacological, therapeutic, cosmetic, or biological effects described above are provided as research context only and do not represent intended or approved uses of this product.

Web ID

– T2709

Storage Temperature

– -20℃

Shipping

– Blue Ice

Molecular Formula

– C28H32N4O3S

Citations

– 1. TAK-901, a novel EPHA2 inhibitor as a therapeutic strategy against prostate cancer[J]. Cellular Signalling, 2025: 111750.

References

– Pamela Farrell, et al, AACR, 2009, Abstract B270

CAS Number

– 934541-31-8

Molecular Weight

– C28H32N4O3S

Compound Purity

– 0.9939

SMILES

– CCS(=O)(=O)c1cccc(c1)-c1cc(C(=O)NC2CCN(C)CC2)c(C)c2[nH]c3ncc(C)cc3c12

Pathway

– Angiogenesis|||JAK/STAT signaling|||Chromatin/Epigenetic|||Tyrosine Kinase/Adaptors|||Cell Cycle/Checkpoint|||Stem Cells

Product type

– Small Compound

Booklet

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.